Literature DB >> 29268557

Completion pneumonectomy after fenestration for empyema due to nontuberculous mycobacteriosis associated with destroyed lung as a result of cancer surgery.

Ryo Takahashi1,2,3, Taiki Fujiwara1,2, Hisami Yamakawa1,2.   

Abstract

Long-term follow-up of post-operative lung cancer patients indicates that some patients develop lung complications. Destroyed lung cannot be ignored because it predisposes the patient to recurrent infection. We report a case of thoracic empyema with bronchopleural fistula that developed in lung tissue damaged due to cancer surgery and associated with an infection of Mycobacterium gordonae (M. gordonae); a class of bacterium responsible for nontuberculous mycobacterial infection. The patient's cancer did not recur after surgery and followed a typical course that began with sub-pleural cystitis followed by repeated infection. We performed fenestration because the patient developed fistulous empyema and the infection became difficult to control using antibiotics. The patient then underwent a radical pleuropneumonectomy and his postoperative course was excellent. Thus, in cases of impaired lung function due to cancer surgery and where pharmacologic control of infection is challenging, we suggest that radical surgical intervention should be considered.

Entities:  

Keywords:  Completion pneumonectomy; Mycobacterium gordonae (M. gordonae); destroyed lung; fenestration; nontuberculous mycobacteriosis

Year:  2017        PMID: 29268557      PMCID: PMC5721030          DOI: 10.21037/jtd.2017.10.72

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  14 in total

Review 1.  An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases.

Authors:  David E Griffith; Timothy Aksamit; Barbara A Brown-Elliott; Antonino Catanzaro; Charles Daley; Fred Gordin; Steven M Holland; Robert Horsburgh; Gwen Huitt; Michael F Iademarco; Michael Iseman; Kenneth Olivier; Stephen Ruoss; C Fordham von Reyn; Richard J Wallace; Kevin Winthrop
Journal:  Am J Respir Crit Care Med       Date:  2007-02-15       Impact factor: 21.405

2.  [Pulmonary infection caused by Mycobacterium gordonae in immunocompetent patient].

Authors:  Y Fujita; H Matsumoto; T Fujikane; S Nakao; N Sasaki; M Takahashi; K Sato; A Takeda; Y Yamazaki; K Tobise
Journal:  Kekkaku       Date:  2000-04

3.  Pneumonectomy through an empyema.

Authors:  J A Odell; B J Henderson
Journal:  J Thorac Cardiovasc Surg       Date:  1985-03       Impact factor: 5.209

4.  [Pulmonary infection caused by Mycobacterium gordonae].

Authors:  N Yanagisawa; D Miyamoto; Y Ichinose; K Toyama
Journal:  Kansenshogaku Zasshi       Date:  1999-05

5.  Completion pneumonectomy: factors affecting operative mortality and cardiopulmonary morbidity.

Authors:  Daniel L Miller; Claude Deschamps; Gregory D Jenkins; Alain Bernard; Mark S Allen; Peter C Pairolero
Journal:  Ann Thorac Surg       Date:  2002-09       Impact factor: 4.330

6.  Nontuberculous mycobacteria: incidence in Southwest Ireland from 1987 to 2000.

Authors:  M P Kennedy; T M O'Connor; C Ryan; S Sheehan; B Cryan; C Bredin
Journal:  Respir Med       Date:  2003-03       Impact factor: 3.415

7.  Factors affecting early and long-term outcomes after completion pneumonectomy.

Authors:  Olivier Chataigner; Elie Fadel; Bedrettin Yildizeli; Abdallah Achir; Sacha Mussot; Dominique Fabre; Olaf Mercier; Philippe G Dartevelle
Journal:  Eur J Cardiothorac Surg       Date:  2008-03-14       Impact factor: 4.191

8.  Nontuberculous mycobacteria in non-HIV patients: epidemiology, treatment and response.

Authors:  M T Henry; L Inamdar; D O'Riordain; M Schweiger; J P Watson
Journal:  Eur Respir J       Date:  2004-05       Impact factor: 16.671

9.  Surgical management of pleuropulmonary tuberculosis.

Authors:  J Mouroux; J Maalouf; B Padovani; C Rotomondo; H Richelme
Journal:  J Thorac Cardiovasc Surg       Date:  1996-03       Impact factor: 5.209

10.  Epidemiology of nontuberculous mycobacteria in patients without HIV infection, New York City.

Authors:  Ethan E Bodle; Jennifer A Cunningham; Phyllis Della-Latta; Neil W Schluger; Lisa Saiman
Journal:  Emerg Infect Dis       Date:  2008-03       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.